Jesus Moreno-Fernandez

Jesus Moreno-Fernandez

Auto-generated profile, based on publicly available information

Jesus Moreno-Fernandez

Ciudad Real General University Hospital, Spain

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2023 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
PBPilar Isabel Beato-Víbora
Pilar Isabel Beato-Víbora
ACAna Chico
Ana Chico
JMJesus Moreno-Fernandez
Jesus Moreno-Fernandez
VBVirginia Bellido
Virginia Bellido
LNLía Nattero-Chávez
Lía Nattero-Chávez
CARMEN QuirósCARMEN Quirós
CARMEN Quirós
OBJECTIVE: Advanced hybrid closed-loop systems (AHCL) have been shown to improve glycemic control and patient-reported outcomes in type 1 diabetes. The aim was to analyze the outcomes of two commercially available AHCL in real life. RESEARCH DESIGN AND METHODS: A prospective study was performed, including adolescents and adults with type 1 diabetes, AHCL naïve, from 14 centers, who initiated the use of MM780G with SmartGuard or Tandem t:slimX2 with Control-IQ. Baseline and 3-month evaluations were performed, assessing HbA1c, time in different glycemic ranges, and patient-reported outcomes. The primary outcome was the between-group time in range 70–180 mg/dL difference from beginning to end of follow-up. RESULTS: One hundred fifty participants were included, with 75 initiating each system (age: 39.9 ± 11.4 years [16–72]; 64% female; diabetes duration: 21.6 ± 11.9 years). Time in range increased from 61.53 ± 14.01% to 76.17 ± 9.48% (P < 0.001), with no between-group differences (P = 0.591). HbA1c decreased by 0.56% (95% CI 0.44%, 0.68%) (6 mmol/mol, 95% CI 5, 7) (P < 0.001), from 7.43 ± 1.07% to 6.88 ± 0.60% (58 ± 12 to 52 ± 7 mmol/mol) in the MM780G group, and from 7.14 ± 0.70% to 6.56 ± 0.53% (55 ± 8 to 48 ± 6 mmol/mol) in the Control-IQ group (both P < 0.001 to baseline, P = 0.819 between groups). No superiority of one AHCL over the other regarding fear of hypoglycemia or quality of life was found. Improvement in diabetes-related distress was higher in Control-IQ users (P = 0.012). Sleep quality was improved (PSQI: from 6.94 ± 4.06 to 6.06 ± 4.05, P = 0.004), without differences between systems. Experience with AHCL, evaluated by the INSPIRE measures, exceeded the expectations. CONCLUSIONS: The two AHCL provide significant improvement in glucose control and satisfaction, with no superiority of one AHCL over the other.

1 May 2021 in AACE Clinical Case Reports
Verified
Journal Article
Open access
JMJesús Moreno-Fernández
Jesús Moreno-Fernández
JGJosé Alberto García-Seco
José Alberto García-Seco
Hybrid closed-loop (HCL) devices can achieve tight glycemic control but are rarely used in pregnancy, which remains an off-label indication. We present a case of a pregnant patient with type 1 diabetes mellitus (T1DM) who used the Medtronic MiniMed 670G HCL system. MiniMed 670G includes an advanced automode option (HCL therapy), which our patient used from the first trimester to the end of the pregnancy. An unplanned pregnancy was detected in the T1DM patient, with a glycated hemoglobin level of 8.7 mmol/L (7.1%). The patient started sensor-augmented pump therapy at week 13. Subsequently, she entered automode (HCL) at week 16. The time in range (3.7-7.8 mmol/mol, 63-140 mg/dL) increased from 46.8% to 51.3% after HCL initiation. The glycated hemoglobin level remained close to 48 mmol/mol (6.5%) until the end of the pregnancy. Furthermore, the time under range (<3.7 mmol/mol, <63 mg/dL) remained below the optimal 4% level during the gestation. Finally, a healthy male baby was born at week 37. No safety events were recorded. This case represents the successful off-label use of HCL during pregnancy in a patient with T1DM.

20 October 2023 in Diabetes Therapy
Verified
Journal Article
Open access
PDF file
ACAna Chico
Ana Chico
JMJesús Moreno-Fernández
Jesús Moreno-Fernández
DFDiego Fernández-García
Diego Fernández-García
ESEva Solá
Eva Solá
Technological advances in the management of diabetes, especially type 1 diabetes (T1D), have played a main role in significantly improving glycemic control of these patients in recent years. Undoubtedly, the most important advance has been the commercialization of hybrid closed-loop systems (HCL). Their effectiveness places them in the different guidelines from scientific societies as the gold standard for the treatment of people with T1D. However, obtaining the maximum performance from these systems requires a degree of expertise from the professionals who care for these patients. Specifically, the Tandem X2:slim with Control-IQ technology system, due to its features and configuration options and adjustments, allows T1D patients to better adapt the management of diabetes to multiple circumstances in their day-to-day life. It is necessary, however, to follow a systematic process to start the system and also for the subsequent follow-up, which allows its optimization in the shortest possible time. This expert recommendation reviews the main features of this HCL system, suggesting how to implement it and optimize its use after gaining experience treating many patients.

1 August 2020 in Primary Care Diabetes
Verified
Journal Article
Closed access
JMJesús Moreno-Fernández
Jesús Moreno-Fernández
JGJosé Alberto García-Seco
José Alberto García-Seco
ERElena María Ortega Rodrigo
Elena María Ortega Rodrigo
ASAngela María Seco Segura
Angela María Seco Segura
FGFernando García-Seco
Fernando García-Seco
JMJosé Ramón Muñoz-Rodríguez
José Ramón Muñoz-Rodríguez

1 December 2018 in Endocrinología, Diabetes y Nutrición
Verified
Journal Article
Closed access
JMJesus Moreno-Fernandez
Jesus Moreno-Fernandez
MPMarcos Pazos-Couselo
Marcos Pazos-Couselo
MGMaria González-Rodriguez
Maria González-Rodriguez
PRPedro Rozas
Pedro Rozas
MDManuel Delgado
Manuel Delgado
JGJose Manuel Garcia-Lopez
Jose Manuel Garcia-Lopez

31 December 2011 in Endocrinología y Nutrición
Verified
Journal Article
Closed access
CGCarmen Gutiérrez-Alcántara
Carmen Gutiérrez-Alcántara
JMJesús Moreno-Fernández
Jesús Moreno-Fernández
RPRafael Palomares-Ortega
Rafael Palomares-Ortega
ÁGÁlvaro García-Manzanares
Álvaro García-Manzanares
PBPedro Benito-López
Pedro Benito-López